Last update:
Weight management news
Warm temperatures curb appetite but can still promote weight gain, animal experiments find
Researchers at Pennington Biomedical Research Center have identified a key brain mechanism that connects environmental temperature with appetite and energy balance, offering new insight into how external conditions can shape ...
8 hours ago
0
3
Inflammation may push people with obesity toward easier, often less healthy food choices
Around half of people who are severely overweight have mild inflammation in their bodies. Research by neuroscientist Judith Scholing of the Donders Institute at Radboud University shows that this inflammation can cause people ...
9 hours ago
0
6
No detectable increase in pregnancy risks after GLP-1 exposure around conception, largest review to date finds
Exposure to GLP-1 weight-loss and diabetes drugs around conception is not linked to a clearly detectable increase in adverse outcomes for mothers or babies, according to the largest study of its kind, involving more than ...
11 hours ago
0
4
Health records from 68 adults link plant-based grocery support to lower blood pressure and weight
Providing people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension. However, most studies of "Food Is Medicine" programs have only looked at their short-term ...
Oct 4, 2026
0
77
New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells
Details of a new injection that targets fat cells will be released at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2). Studies show that the new drug, CBL-514, ...
Oct 2, 2026
0
2905
Low-calorie diet and exercise put early-onset type 2 diabetes in remission for 54% of participants
New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and appearing in The Lancet Regional Health Americas journal shows that in people ...
Oct 2, 2026
0
361
A molecular switch syncs fat burning to the body clock, our diet and the temperature around us
Brown fat burns fuel to make heat, and this activity is controlled by the body clock: It drops during sleep and rises before waking. But a cold morning or a skipped meal makes demands the clock never planned for. How the ...
Oct 1, 2026
0
22
New triple agonist drug produces substantial weight loss in diabetic patients
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and appearing in The Lancet shows that treatment with the new triple agonist ...
Oct 1, 2026
0
97
GLP-1 prescriptions for new mothers have increased sharply
More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
Oct 1, 2026
0
15
Clinical trial provides preliminary evidence of blood-pressure effect from feijoa
The world's first clinical trial of feijoa has provided preliminary evidence that the fruit reduces blood pressure during weight loss. The unexpected finding was incidental to studying feijoa's potential for preventing type ...
Oct 1, 2026
0
73
Experimental obesity drug targets appetite through amylin, offering potential alternative to GLP-1 therapies
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Diabetes & Endocrinology shows that weekly injections ...
Sep 30, 2026
0
82
Focusing on the 'obesity paradox' to improve cancer treatment success
In research published in the journal Nature, McGill University researchers looked at the relationship between diet, the gut microbiome and patient response to immune checkpoint blockade. To their surprise, certain diets often ...
Sep 30, 2026
0
23
Trevogrumab (anti-myostatin) can help preserve lean mass during and after semaglutide-induced weight loss
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, and in press at The Lancet shows that trevogrumab, which inhibits a protein that ...
Sep 30, 2026
0
169
Daily pill could offer alternative to insulin injections for diabetes patients at cardiovascular risk
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, and published in The Lancet shows that, for people with type 2 diabetes at increased ...
Sep 30, 2026
0
24
GLP-1s appear safe for treating diabetes in pregnancy, but evidence gaps remain
New research to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Obstetrics, Gynaecology & Women's Health shows ...
Sep 30, 2026
0
19
Higher GLP-1 costs lead to lower adherence
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
7
New investigational drug delivers up to 23.3% weight loss in people with obesity and diabetes
New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), show that, for people living with obesity and type ...
Sep 30, 2026
0
114
Women are and will be the predominant users of GLP-1 users, but research gaps remain critical
The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28—Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health ...
Sep 30, 2026
0
7
Real-world findings suggest GLP-1 drugs offer health benefits for young people with diabetes
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1 receptor agonist (GLP-1 RA) drugs in children ...
Sep 30, 2026
0
3
Major trial examines sugar-free sweetened soft drinks
Researchers at the University of Liverpool have conducted the longest and most comprehensive randomized controlled trial of non-nutritive sweetened (NNS) soft drinks.
Sep 29, 2026
0
1161
Cutting calories sheds weight initially, but body changes can drive regain
In the last few years, there's been a lot of interest in calorie-restricted diets for weight loss.
Sep 29, 2026
0
11
Q&A: What are ultra-processed foods?
Nearly every day, there's a headline about ultra-processed foods, which have been linked to harmful health effects despite lacking a universally accepted definition. These foods are the subject of numerous proposed regulations, ...
Sep 29, 2026
0
5
EU launches first Screening Week to help detect heart and diabetes risks earlier
At a press conference at the EASD Annual Meeting in Milan, organized by the European Diabetes Forum (EUDF), three leading European cardiometabolic scientific associations—the European Society of Cardiology (ESC), the European ...
Sep 29, 2026
0
4
How much do Americans spend on GLP-1 medications? Medical students measure drug affordability
The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss or chronic conditions has increased rapidly, with more than 1 in 10 U.S. adults currently taking such medications. A new study led by medical ...
Sep 28, 2026
0
11
Regulator-mandated study finds no link between semaglutide use and pancreatic cancer
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry ...
Sep 28, 2026
0
19
